Literature DB >> 35247100

Successful treatment for diffuse large B-cell lymphoma in a Japanese adolescent with PIK3CD germ-line mutation: stem cell transplantation after reduced-intensity conditioning.

Hiroshi Yagasaki1, Maiko Hirai2, Koji Kanezawa2, Masaru Ueno2, Hiroyuki Hao3, Shinobu Masuda4, Masahiko Sugitani3,5, Ichiro Morioka2.   

Abstract

Entities:  

Keywords:  Bone marrow transplantation; Diffuse large B-cell lymphoma; Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue; PIK3CD; Reduced-intensity conditioning; Rituximab

Mesh：

Substances：

Year:  2022        PMID： 35247100     DOI： 10.1007/s00277-022-04809-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  10 in total

1.  Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.

Authors:  Zohreh Nademi; Mary A Slatter; Christopher C Dvorak; Benedicte Neven; Alain Fischer; Felipe Suarez; Claire Booth; Kanchan Rao; Alexandra Laberko; Julia Rodina; Yves Bertrand; Sylwia Kołtan; Robert Dębski; Terence Flood; Mario Abinun; Andrew R Gennery; Sophie Hambleton; Stephan Ehl; Andrew J Cant
Journal:  J Allergy Clin Immunol       Date:  2016-11-12       Impact factor: 10.793

2.  Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.

Authors:  Mahnaz Jamee; Shakiba Moniri; Majid Zaki-Dizaji; Peter Olbrich; Reza Yazdani; Farhad Jadidi-Niaragh; Fatemeh Aghamahdi; Hassan Abolhassani; Alison M Condliffe; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Clin Rev Allergy Immunol       Date:  2020-12       Impact factor: 8.667

3.  Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology.

Authors:  S-T Jou; Y-H Chien; Y-H Yang; T-C Wang; S-D Shyur; C-C Chou; M-L Chang; D-T Lin; K-H Lin; B-L Chiang
Journal:  Int J Immunogenet       Date:  2006-10       Impact factor: 1.466

4.  Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.

Authors:  Tsubasa Okano; Kohsuke Imai; Yuki Tsujita; Noriko Mitsuiki; Kenichi Yoshida; Chikako Kamae; Kenichi Honma; Kanako Mitsui-Sekinaka; Yujin Sekinaka; Tamaki Kato; Katsuyuki Hanabusa; Eri Endo; Takehiro Takashima; Haruka Hiroki; Tzu-Wen Yeh; Keisuke Tanaka; Masakazu Nagahori; Ikuya Tsuge; Yuki Bando; Fuminori Iwasaki; Yoshiaki Shikama; Masami Inoue; Tomiko Kimoto; Naohiko Moriguchi; Yuki Yuza; Takashi Kaneko; Kyoko Suzuki; Tomoyo Matsubara; Yoshihiro Maruo; Tomoaki Kunitsu; Tomoko Waragai; Hideki Sano; Yuko Hashimoto; Kazuhiro Tasaki; Osamu Suzuki; Toshihiko Shirakawa; Motohiro Kato; Toru Uchiyama; Masataka Ishimura; Tetsuzo Tauchi; Hiroshi Yagasaki; Shiann-Tarng Jou; Hsin-Hui Yu; Hirokazu Kanegane; Sven Kracker; Anne Durandy; Daiei Kojima; Hideki Muramatsu; Taizo Wada; Yuzaburo Inoue; Hidetoshi Takada; Seiji Kojima; Seishi Ogawa; Osamu Ohara; Shigeaki Nonoyama; Tomohiro Morio
Journal:  J Allergy Clin Immunol       Date:  2018-05-18       Impact factor: 10.793

5.  Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.

Authors:  V Koneti Rao; Sharon Webster; Virgil A S H Dalm; Anna Šedivá; P Martin van Hagen; Steven Holland; Sergio D Rosenzweig; Andreas D Christ; Birgitte Sloth; Maciej Cabanski; Aniket D Joshi; Stefan de Buck; Julie Doucet; Danilo Guerini; Christoph Kalis; Ilona Pylvaenaeinen; Nicolas Soldermann; Anuj Kashyap; Gulbu Uzel; Michael J Lenardo; Dhavalkumar D Patel; Carrie L Lucas; Christoph Burkhart
Journal:  Blood       Date:  2017-09-29       Impact factor: 22.113

6.  Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.

Authors:  Mara Compagno; Qi Wang; Chiara Pighi; Taek-Chin Cheong; Fei-Long Meng; Teresa Poggio; Leng-Siew Yeap; Elif Karaca; Rafael B Blasco; Fernanda Langellotto; Chiara Ambrogio; Claudia Voena; Adrian Wiestner; Siddha N Kasar; Jennifer R Brown; Jing Sun; Catherine J Wu; Monica Gostissa; Frederick W Alt; Roberto Chiarle
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962

7.  Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

Authors:  Maria Elena Maccari; Hassan Abolhassani; Asghar Aghamohammadi; Alessandro Aiuti; Olga Aleinikova; Catherine Bangs; Safa Baris; Federica Barzaghi; Helen Baxendale; Matthew Buckland; Siobhan O Burns; Caterina Cancrini; Andrew Cant; Pascal Cathébras; Marina Cavazzana; Anita Chandra; Francesca Conti; Tanya Coulter; Lisa A Devlin; J David M Edgar; Saul Faust; Alain Fischer; Marina Garcia-Prat; Lennart Hammarström; Maximilian Heeg; Stephen Jolles; Elif Karakoc-Aydiner; Gerhard Kindle; Ayca Kiykim; Dinakantha Kumararatne; Bodo Grimbacher; Hilary Longhurst; Nizar Mahlaoui; Tomas Milota; Fernando Moreira; Despina Moshous; Anna Mukhina; Olaf Neth; Benedicte Neven; Alexandra Nieters; Peter Olbrich; Ahmet Ozen; Jana Pachlopnik Schmid; Capucine Picard; Seraina Prader; William Rae; Janine Reichenbach; Stephan Rusch; Sinisa Savic; Alessia Scarselli; Raphael Scheible; Anna Sediva; Svetlana O Sharapova; Anna Shcherbina; Mary Slatter; Pere Soler-Palacin; Aurelie Stanislas; Felipe Suarez; Francesca Tucci; Annette Uhlmann; Joris van Montfrans; Klaus Warnatz; Anthony Peter Williams; Phil Wood; Sven Kracker; Alison Mary Condliffe; Stephan Ehl
Journal:  Front Immunol       Date:  2018-03-16       Impact factor: 7.561

Review 8.  Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Authors:  Jean-Marie Carpier; Carrie L Lucas
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

9.  Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

Authors:  Tanya I Coulter; Anita Chandra; Chris M Bacon; Judith Babar; James Curtis; Nick Screaton; John R Goodlad; George Farmer; Cathal Laurence Steele; Timothy Ronan Leahy; Rainer Doffinger; Helen Baxendale; Jolanta Bernatoniene; J David M Edgar; Hilary J Longhurst; Stephan Ehl; Carsten Speckmann; Bodo Grimbacher; Anna Sediva; Tomas Milota; Saul N Faust; Anthony P Williams; Grant Hayman; Zeynep Yesim Kucuk; Rosie Hague; Paul French; Richard Brooker; Peter Forsyth; Richard Herriot; Caterina Cancrini; Paolo Palma; Paola Ariganello; Niall Conlon; Conleth Feighery; Patrick J Gavin; Alison Jones; Kohsuke Imai; Mohammad A A Ibrahim; Gašper Markelj; Mario Abinun; Frédéric Rieux-Laucat; Sylvain Latour; Isabelle Pellier; Alain Fischer; Fabien Touzot; Jean-Laurent Casanova; Anne Durandy; Siobhan O Burns; Sinisa Savic; D S Kumararatne; Despina Moshous; Sven Kracker; Bart Vanhaesebroeck; Klaus Okkenhaug; Capucine Picard; Sergey Nejentsev; Alison M Condliffe; Andrew James Cant
Journal:  J Allergy Clin Immunol       Date:  2016-07-16       Impact factor: 10.793

10.  Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort.

Authors:  Jessica Oh; Elizabeth Garabedian; Ramsay Fuleihan; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2021-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.